Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
Le Lézard8h
Teva and Alvotech Announce SELARSDItm (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
Suffering from psoriasis? Not surprisingly, sodium might be contributing
We’ve known for some time that many chronic conditions are exacerbated by excess sodium intake. A new study links overuse of ...
dermatologyadvisor2d
Psoriasis Risk Increases With Higher Sodium Intake
Results from 2 population-based cohorts demonstrate that psoriasis risk is increased among patients with higher intake of dietary sodium.
Medpage Today on MSN3d
Some Psoriasis Biologics Better Than Others for Preventing Progression to PsA
Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or IL-23 inhibitors compared with those receiving tumor necrosis factor (TNF) ...